Published on
Apr 4, 2026
<![CDATA[The New Era of U.S. Pharmaceutical Pricing: From Policy Upheaval to Strategic Adaptation]]>
Introduction The U.S. pharmaceutical market is at a critical inflection point in early 2026. For decades, the industry has operated within a framework that, while fostering significant innovation, has also resulted in the highest prescription drug prices …
Source:
Pharmaceutical Executive
-
Pending
